Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

A Clinical Trial for CTD-ILD Treatment
Clinical Trial of Oral Medication for CTD-ILD Treatment
Status: Enrolling
Updated:  1/14/2016
University of Michigan
mi
from
Ann Arbor, MI
A Clinical Trial for CTD-ILD Treatment
Clinical Trial of Oral Medication for CTD-ILD Treatment
Status: Enrolling
Updated: 1/14/2016
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)
A Radiographic Analysis Using PureGen Osteoprogenitor Cell Allograft Versus Autologous Bone in Posterolateral Fusion in a Side-by-Side Comparison in the Same Patient (PLF)
Status: Enrolling
Updated:  1/15/2016
Clinical Research Facility
mi
from
Beverly Hills, CA
Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)
A Radiographic Analysis Using PureGen Osteoprogenitor Cell Allograft Versus Autologous Bone in Posterolateral Fusion in a Side-by-Side Comparison in the Same Patient (PLF)
Status: Enrolling
Updated: 1/15/2016
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)
Radiographic and Clinical Outcomes of PureGen Osteoprogenitor Cell Allograft in Posterior Lumbar and Transforaminal Interbody Fusion Procedures
Status: Enrolling
Updated:  1/15/2016
Clinical Research Facility
mi
from
Beverly Hills, CA
Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)
Radiographic and Clinical Outcomes of PureGen Osteoprogenitor Cell Allograft in Posterior Lumbar and Transforaminal Interbody Fusion Procedures
Status: Enrolling
Updated: 1/15/2016
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)
Radiographic and Clinical Outcomes of PureGen Osteoprogenitor Cell Allograft in Posterior Lumbar and Transforaminal Interbody Fusion Procedures
Status: Enrolling
Updated:  1/15/2016
mi
from
Middleton, CT
Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)
Radiographic and Clinical Outcomes of PureGen Osteoprogenitor Cell Allograft in Posterior Lumbar and Transforaminal Interbody Fusion Procedures
Status: Enrolling
Updated: 1/15/2016
mi
from
Middleton, CT
Click here to add this to my saved trials
Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)
Radiographic and Clinical Outcomes of PureGen Osteoprogenitor Cell Allograft in Posterior Lumbar and Transforaminal Interbody Fusion Procedures
Status: Enrolling
Updated:  1/15/2016
Clinical Research Facility
mi
from
Greensboro, NC
Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)
Radiographic and Clinical Outcomes of PureGen Osteoprogenitor Cell Allograft in Posterior Lumbar and Transforaminal Interbody Fusion Procedures
Status: Enrolling
Updated: 1/15/2016
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
Functional Movement Retraining After Hip Replacement
Functional Movement Retraining After Hip Arthroplasty in Veterans: Pilot Study
Status: Enrolling
Updated:  1/15/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Functional Movement Retraining After Hip Replacement
Functional Movement Retraining After Hip Arthroplasty in Veterans: Pilot Study
Status: Enrolling
Updated: 1/15/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Functional Movement Retraining After Hip Replacement
Functional Movement Retraining After Hip Arthroplasty in Veterans: Pilot Study
Status: Enrolling
Updated:  1/15/2016
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Functional Movement Retraining After Hip Replacement
Functional Movement Retraining After Hip Arthroplasty in Veterans: Pilot Study
Status: Enrolling
Updated: 1/15/2016
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Click here to add this to my saved trials
Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis
Slow Wave Sleep and Inflammatory Processes in Pain
Status: Enrolling
Updated:  1/18/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Sleep, Pain and Inflammatory Processes in Older Adults With Osteoarthritis
Slow Wave Sleep and Inflammatory Processes in Pain
Status: Enrolling
Updated: 1/18/2016
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
A Phase II Study to Determine the Efficacy and Safety of Allogeneic Human Chondrocytes Expressing TGF-β1 (TissueGene-C) in Patients With Grade 3 Chronic Degenerative Joint Disease of the Knee
Status: Enrolling
Updated:  1/19/2016
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
A Phase II Study to Determine the Efficacy and Safety of Allogeneic Human Chondrocytes Expressing TGF-β1 (TissueGene-C) in Patients With Grade 3 Chronic Degenerative Joint Disease of the Knee
Status: Enrolling
Updated: 1/19/2016
Sinai Hospital of Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
A Phase II Study to Determine the Efficacy and Safety of Allogeneic Human Chondrocytes Expressing TGF-β1 (TissueGene-C) in Patients With Grade 3 Chronic Degenerative Joint Disease of the Knee
Status: Enrolling
Updated:  1/19/2016
Commonwealth Orthopedics
mi
from
Arlington, VA
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
A Phase II Study to Determine the Efficacy and Safety of Allogeneic Human Chondrocytes Expressing TGF-β1 (TissueGene-C) in Patients With Grade 3 Chronic Degenerative Joint Disease of the Knee
Status: Enrolling
Updated: 1/19/2016
Commonwealth Orthopedics
mi
from
Arlington, VA
Click here to add this to my saved trials
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
A Phase II Study to Determine the Efficacy and Safety of Allogeneic Human Chondrocytes Expressing TGF-β1 (TissueGene-C) in Patients With Grade 3 Chronic Degenerative Joint Disease of the Knee
Status: Enrolling
Updated:  1/19/2016
Advent Clinical Research
mi
from
Pinellas Park, FL
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
A Phase II Study to Determine the Efficacy and Safety of Allogeneic Human Chondrocytes Expressing TGF-β1 (TissueGene-C) in Patients With Grade 3 Chronic Degenerative Joint Disease of the Knee
Status: Enrolling
Updated: 1/19/2016
Advent Clinical Research
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
A Phase II Study to Determine the Efficacy and Safety of Allogeneic Human Chondrocytes Expressing TGF-β1 (TissueGene-C) in Patients With Grade 3 Chronic Degenerative Joint Disease of the Knee
Status: Enrolling
Updated:  1/19/2016
Rothman Institute
mi
from
Philadelphia, PA
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
A Phase II Study to Determine the Efficacy and Safety of Allogeneic Human Chondrocytes Expressing TGF-β1 (TissueGene-C) in Patients With Grade 3 Chronic Degenerative Joint Disease of the Knee
Status: Enrolling
Updated: 1/19/2016
Rothman Institute
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
A Phase II Study to Determine the Efficacy and Safety of Allogeneic Human Chondrocytes Expressing TGF-β1 (TissueGene-C) in Patients With Grade 3 Chronic Degenerative Joint Disease of the Knee
Status: Enrolling
Updated:  1/19/2016
University Orthopedics
mi
from
State College, PA
Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee
A Phase II Study to Determine the Efficacy and Safety of Allogeneic Human Chondrocytes Expressing TGF-β1 (TissueGene-C) in Patients With Grade 3 Chronic Degenerative Joint Disease of the Knee
Status: Enrolling
Updated: 1/19/2016
University Orthopedics
mi
from
State College, PA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
University of California, Irvine - Dermatology Research
mi
from
Irvine, CA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
University of California, Irvine - Dermatology Research
mi
from
Irvine, CA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Plastic Surgery and Laser Institute of San Diego
mi
from
La Jolla, CA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Plastic Surgery and Laser Institute of San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Scripps Memorial-Ximed Medical Center
mi
from
La Jolla, CA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Scripps Memorial-Ximed Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Advanced Cosmetic Surgery Clinic of Walnut Creek
mi
from
Walnut Creek, CA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Advanced Cosmetic Surgery Clinic of Walnut Creek
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Anthony DeMeo, MD
mi
from
Walnut Creek, CA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Anthony DeMeo, MD
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Charles Hanson MD
mi
from
Walnut Creek, CA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Charles Hanson MD
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
PIH Health Plastic Surgery and Aesthetic Medicine
mi
from
Whittier, CA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
PIH Health Plastic Surgery and Aesthetic Medicine
mi
from
Whittier, CA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
PIH health
mi
from
Whittier, CA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
PIH health
mi
from
Whittier, CA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Sanctuary Mediacal Center
mi
from
Boca Raton, FL
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Sanctuary Mediacal Center
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Stephan Baker, MD PA
mi
from
Coral Gables, FL
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Stephan Baker, MD PA
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Altus Research
mi
from
Lake Worth, FL
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Altus Research
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Bayside Ambulatory Center
mi
from
Miami, FL
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Bayside Ambulatory Center
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
University of South Florida
mi
from
Tampa, FL
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Atlanta APC Plastic Surgery
mi
from
Atlanta, GA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Atlanta APC Plastic Surgery
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Kavali Plastic Surgery and Skin Renewal Center
mi
from
Atlanta, GA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Kavali Plastic Surgery and Skin Renewal Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Perimeter Outpatient Surgery Center
mi
from
Atlanta, GA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Perimeter Outpatient Surgery Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Advanced Medical Resarch ,Inc
mi
from
Atlanta, GA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Advanced Medical Resarch ,Inc
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Atlanta APC Plastic Surgery
mi
from
Conyers, GA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Atlanta APC Plastic Surgery
mi
from
Conyers, GA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Spivey Station Surgery Center
mi
from
Jonesboro, GA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Spivey Station Surgery Center
mi
from
Jonesboro, GA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Northwestern University Diagnostic Testing Center
mi
from
Chicago, IL
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Northwestern University Diagnostic Testing Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Northwestern University,Division of Plastic Surgery
mi
from
Chicago, IL
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Northwestern University,Division of Plastic Surgery
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Body Aesthetic Research Center
mi
from
Saint Louis, MO
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Body Aesthetic Research Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Mercy Clinic Heart and Vascular
mi
from
St. Louis, MO
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Mercy Clinic Heart and Vascular
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Long Island Plastic Surgical Group
mi
from
Garden City, NY
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Long Island Plastic Surgical Group
mi
from
Garden City, NY
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Long Island Plastic Surgical Group, PC
mi
from
Manhasset, NY
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Long Island Plastic Surgical Group, PC
mi
from
Manhasset, NY
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Laser & Skin Surgery Center of NY
mi
from
New York, NY
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Laser & Skin Surgery Center of NY
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
The Hunstad Kortesis Center for Cosmetic Surgery
mi
from
Huntersville, NC
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
The Hunstad Kortesis Center for Cosmetic Surgery
mi
from
Huntersville, NC
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Connall Consmetic Surgery
mi
from
Tualatin, OR
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Connall Consmetic Surgery
mi
from
Tualatin, OR
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Meridian Center for Surgical Excellence, LLC
mi
from
Tualatin, OR
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Meridian Center for Surgical Excellence, LLC
mi
from
Tualatin, OR
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Timothy P. Connall, MD PC
mi
from
Tualatin, OR
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Timothy P. Connall, MD PC
mi
from
Tualatin, OR
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Office of Paul M. Glat ,MD
mi
from
Bala Cynwyd, PA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Office of Paul M. Glat ,MD
mi
from
Bala Cynwyd, PA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Black Hill Surgical Hospital
mi
from
Rapid City, SD
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Black Hill Surgical Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Health Concepts
mi
from
Rapid City, SD
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Health Concepts
mi
from
Rapid City, SD
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Fort Bend Imaging
mi
from
Sugar Land, TX
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Fort Bend Imaging
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Luxe Plastic Surgery
mi
from
Sugar Land, TX
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Luxe Plastic Surgery
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated:  1/19/2016
Noahklinik,Klinik Plastische, Rekonstruktive und Asthetische Chirurgie, Handchirurgie am Roten Kreuz
mi
from
Kassel,
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring
Status: Enrolling
Updated: 1/19/2016
Noahklinik,Klinik Plastische, Rekonstruktive und Asthetische Chirurgie, Handchirurgie am Roten Kreuz
mi
from
Kassel,
Click here to add this to my saved trials